Intellipharmaceutics International Inc.

The US Food and Drug Administration continues to lean on providers to change their prescribing habits with newly implemented opioid labeling changes, but whether the message will reach them remains un

Two US Food and Drug Advisory Committees will finally get to look at postmarket data to determine whether Purdue Pharma L.P. ’s reformulated OxyContin actually deters abuse and misuse. The analysis c

Controlled-release and targeted-release oral solids specialist Intellipharmaceutics has offered a sober summary of its finances in the wake of a US Food and Drug Administration committee decision re

Who will be the first sponsor to take an application to a “virtual” advisory committee hosted by the US Food & Drug Administration? While one can always hope that the COVID-19 outbreak recedes quickly